Adding Value to Biomarker Development from the Regulatory Perspective
Patricia Hurley, Head of Biomarkers, ERA Consulting, speaking at European Biomarkers Summit 2010.
Approaches for the Identification of New Biomarkers for Alzheimer's Disease
Christian Czech, CNS Researcher, F. Hoffman-La Roche, speaking at European Biomarkers Summit 2010.
Urine Molecular Profiling Distinguishes Health and Disease: A Fresh View on Diagnostics
Simone Koenig, Professor, University of Munster, speaking at European Biomarkers Summit 2010.
Metabolomics and Proteomics Data Integration: From Single Model Organisms to Ecosystems
Wolfram Weckwerth, University of Vienna, speaking at Advances in Metabolic Profiling 2010.
The OPPF-UK Pipeline for Structural Proteomics of Glycoproteins
Joanne Nettleship, Senior Scientist, Oxford Protein Production, speaking at Advances in Protein Crystallography 2010.
Biomarkers of Metabolic Syndrome in Clinical Trials
This will discuss the latest developments in biomarkers for metabolic syndrome. The topics will include: 1) Pre-analytical and analytical concerns regarding gut and incretin hormones, 2) dysfunctional HDL biomarkers in metabolic syndrome, and 3) kidney injury markers and their usefulness in diabetic nephropathy.
Progression of HCV Infection to Hepatocellular Carcinoma
Radoslav Goldman, Associate Professor, Georgetown University, speaking at European Biomarkers Summit 2010.
A Novel Strategy for Bespoke Tissue-Specific Biomarkers for Drug Development
Gary Coulton, Director, University of London, speaking at European Biomarkers Summit 2010.
Procalcitonin (PCT) Webinar - How to Incorporate Procalcitonin (PCT) into your Facility's Sepsis Initiative
In this webinar Kirsten R. Pyle-Springer, Sepsis Coordinator at Surgical/Neuro/Trauma Intensive Care Unit, Mission Hospital in Mission Viejo, California discusses the Awareness of Sepsis and the risk of Sepsis in critical care settings.